Total Payments
$670.16
2024 Payments
$188.52
Companies
12
Transactions
22
Medicare Patients
2,966
Medicare Billing
$320,853
Payment Breakdown by Category
Food & Beverage$670.16 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $670.16 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Enterra Medical, Inc. | $145.37 | 1 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $110.58 | 1 | $0 (2017) |
| Ethicon Inc. | $93.19 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $90.44 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $41.57 | 3 | $0 (2023) |
| PFIZER INC. | $36.59 | 2 | $0 (2024) |
| ABBVIE INC. | $35.11 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.96 | 5 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $27.57 | 2 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $26.62 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.52 | 3 | Enterra Medical, Inc. ($145.37) |
| 2023 | $13.59 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($13.59) |
| 2022 | $14.88 | 1 | ABBVIE INC. ($14.88) |
| 2021 | $15.52 | 1 | Intercept Pharmaceuticals, Inc. ($15.52) |
| 2019 | $63.57 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($34.96) |
| 2018 | $129.07 | 4 | Merck Sharp & Dohme Corporation ($90.44) |
| 2017 | $245.01 | 5 | BOSTON SCIENTIFIC CORPORATION ($110.58) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/15/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $145.37 | General |
| 06/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Gastroenterology | ||||||
| 07/20/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: IMMUNOLOGY | ||||||
| 01/07/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 08/13/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Lower GI | ||||||
| 06/17/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Motegrity (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Lower GI | ||||||
| 05/14/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: Lower GI | ||||||
| 04/10/2019 | Romark Laboratories, LC | Alinia (Drug), Alinia, Alinia | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Gastroenterology | ||||||
| 02/05/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 01/16/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Lower GI | ||||||
| 01/16/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $0.58 | General |
| Category: Lower GI | ||||||
| 08/20/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/11/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $90.44 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/03/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS TABLETS (Drug), APRISO, UCERIS FOAM | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/02/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | APRISO (Drug), UCERIS TABLETS | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2017 | BOSTON SCIENTIFIC CORPORATION | SPYGLASS (Device) | Food and Beverage | In-kind items and services | $110.58 | General |
| Category: BILIARY DEVICES | ||||||
| 09/27/2017 | Ethicon Inc. | LINX Reflux Management System (Device) | Food and Beverage | Cash or cash equivalent | $93.19 | General |
| Category: Endo-Mechanical | ||||||
| 08/28/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2017 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: INFLAMMATION | ||||||
| 02/02/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 619 | 697 | $401,668 | $69,234 |
| 2022 | 12 | 721 | 779 | $438,198 | $77,683 |
| 2021 | 13 | 778 | 861 | $419,768 | $87,234 |
| 2020 | 13 | 848 | 1,009 | $437,476 | $86,703 |
Total Patients
2,966
Total Services
3,346
Medicare Billing
$320,853
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 167 | $56,279 | $14,128 | 25.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 69 | 69 | $87,078 | $13,405 | 15.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 39 | 39 | $34,554 | $6,552 | 19.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 70 | 70 | $55,328 | $5,356 | 9.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $25,002 | $5,074 | 20.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 73 | $16,790 | $4,424 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 32 | $13,600 | $4,085 | 30.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 77 | 79 | $48,458 | $3,813 | 7.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $15,260 | $3,501 | 22.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 36 | $12,600 | $3,282 | 26.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 25 | 26 | $20,018 | $2,081 | 10.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $6,955 | $2,006 | 28.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $9,746 | $1,527 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 197 | $53,231 | $16,713 | 31.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 80 | 80 | $100,329 | $13,668 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 83 | 83 | $32,465 | $8,992 | 27.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 41 | 41 | $36,326 | $6,879 | 18.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 112 | 113 | $72,326 | $6,768 | 9.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 84 | 84 | $67,032 | $6,027 | 9.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 32 | $15,354 | $4,866 | 31.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 51 | $14,638 | $4,005 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 32 | $11,860 | $3,799 | 32.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 16 | 16 | $14,176 | $2,671 | 18.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 19 | 19 | $14,915 | $1,652 | 11.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 31 | $5,546 | $1,641 | 29.6% |
About Dr. Steven Josephson, M.D
Dr. Steven Josephson, M.D is a Gastroenterology healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619925567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Josephson, M.D has received a total of $670.16 in payments from pharmaceutical and medical device companies, with $188.52 received in 2024. These payments were reported across 22 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($670.16).
As a Medicare-enrolled provider, Josephson has provided services to 2,966 Medicare beneficiaries, totaling 3,346 services with total Medicare billing of $320,853. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Huntersville, NC
- Active Since 05/04/2006
- Last Updated 04/04/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1619925567
Products in Payments
- SPYGLASS (Device) $110.58
- LINX Reflux Management System (Device) $93.19
- DIFICID (Drug) $90.44
- XIFAXAN (Drug) $41.16
- RINVOQ (Biological) $35.11
- OCALIVA (Drug) $26.62
- XELJANZ (Drug) $22.92
- Alinia (Drug) $17.51
- Entyvio (Biological) $17.28
- UCERIS TABLETS (Drug) $15.47
- INFLECTRA (Biological) $13.67
- APRISO (Drug) $12.51
- LINZESS (Drug) $10.65
- Motegrity (Drug) $10.21
- Amitiza (Drug) $7.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Huntersville
Dr. Maria Hatara, Md, MD
Gastroenterology — Payments: $8,938
Gastroenterology $8,938
Sharad Nangia, M.d, M.D
Gastroenterology — Payments: $954.45
Gastroenterology $954.45
Dr. Scott Brotze, M.d, M.D
Gastroenterology — Payments: $930.52
Gastroenterology $930.52
Caroline Barrett, M.d, M.D
Gastroenterology — Payments: $728.64
Gastroenterology $728.64
Dr. Devi Thangavelu, M.d, M.D
Gastroenterology — Payments: $693.27
Gastroenterology $693.27
Rebecca Rawl, Md, MD
Gastroenterology — Payments: $594.06
Gastroenterology $594.06